https://orcid.org/0000-0002-3526-7712
References
- DeBrosse, S. D., Okajima, K., Zhang, S., Nakouzi, G., Schmotzer, C. L., Lusk-Kopp, M., Frohnapfel, M. B., Grahame, G., & Kerr, D. S. (2012). Spectrum of neurological and survival outcomes in pyruvate dehydrogenase complex (PDC) deficiency: Lack of correlation with genotype. Molecular Genetics and Metabolism, 107(3), 394–402. https://doi.org/10.1016/j.ymgme.2012.09.001
- Dusi, S., Valletta, L., Haack, T. B., Tsuchiya, Y., Venco, P., Pasqualato, S., Goffrini, P., Tigano, M., Demchenko, N., Wieland, T., Schwarzmayr, T., Strom, T. M., Invernizzi, F., Garavaglia, B., Gregory, A., Sanford, L., Hamada, J., Bettencourt, C., Houlden, H., … Tiranti, V. (2014). Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation. American Journal of Human Genetics, 94(1), 11–22. https://doi.org/10.1016/j.ajhg.2013.11.008
- Friedman, J., Feigenbaum, A., Chuang, N., Silhavy, J., & Gleeson, J. G. (2017). Pyruvate dehydrogenase complex-E2 deficiency causes paroxysmal exercise-induced dyskinesia. Neurology, 89(22), 2297–2298. https://doi.org/10.1212/WNL.0000000000004689
- Head, R. A., Brown, R. M., Zolkipli, Z., Shahdadpuri, R., King, M. D., Clayton, P. T., & Brown, G. K. (2005). Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: Dihydrolipoamide acetyltransferase (E2) deficiency. Annals of Neurology, 58(2), 234–241. https://doi.org/10.1002/ana.20550
- Huq, A. H., Ito, M., Naito, E., Saijo, T., Takeda, E., & Kuroda, Y. (1991). Demonstration of an unstable variant of pyruvate dehydrogenase protein (E1) in cultured fibroblasts from a patient with congenital lactic acidemia. Pediatric Research, 30(1), 11–14. https://doi.org/10.1203/00006450-199107000-00003
- Kruer, M. C., Boddaert, N., Schneider, S. A., Houlden, H., Bhatia, K. P., Gregory, A., Anderson, J. C., Rooney, W. D., Hogarth, P., & Hayflick, S. J. (2012). Neuroimaging features of neurodegeneration with brain iron accumulation. American Journal of Neuroradiology, 33(3), 407–414. https://doi.org/10.3174/ajnr.A2677
- Kumar, N., Boes, C. J., Babovic-Vuksanovic, D., & Boeve, B. F. (2006). The “eye-of-the-tiger” sign is not pathognomonic of the PANK2 mutation. Archives of Neurology, 63(2), 292–293. https://doi.org/10.1001/archneur.63.2.292
- McWilliam, C. A., Ridout, C. K., Brown, R. M., McWilliam, R. C., Tolmie, J., & Brown, G. K. (2010). Pyruvate dehydrogenase E2 deficiency: A potentially treatable cause of episodic dystonia. European Journal of Paediatric Neurology, 14(4), 349–353. https://doi.org/10.1016/j.ejpn.2009.11.001
- Patel, K. P., O'Brien, T. W., Subramony, S. H., Shuster, J., & Stacpoole, P. W. (2012). The spectrum of pyruvate dehydrogenase complex deficiency: Clinical, biochemical, and genetic features in 371 patients. Molecular Genetics and Metabolism, 105(1), 34–43. https://doi.org/10.1016/j.ymgme.2011.09.032
- Patel, M. S., & Roche, T. E. (1990). Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB Journal, 4(14), 3224–3233. https://doi.org/10.1096/fasebj.4.14.2227213
- Robinson, B. H., MacKay, N., Petrova-Benedict, R., Ozalp, I., Coskun, T., & Stacpoole, P. W. (1990). Defects in the E2 lipoyl transacetylase and the X-lipoyl containing component of the pyruvate dehydrogenase complex in patients with lactic acidemia. The Journal of Clinical Investigation, 85(6), 1821–1824. https://doi.org/10.1172/JCI114641
- Schneider, S. A. (2016). Neurodegeneration with brain iron accumulation. Current Neurology and Neuroscience Reports, 16(1), 9. https://doi.org/10.1007/s11910-015-0608-3
- Serajee, F. J., & Huq, A. M. (2015). Homozygous mutation in synaptic vesicle glycoprotein 2A gene results in intractable epilepsy, involuntary movements, microcephaly, and developmental and growth retardation. Pediatric Neurology, 52(6), 642–646.e1. https://doi.org/10.1016/j.pediatrneurol.2015.02.011
- Tonekaboni, S. H., & Mollamohammadi, M. (2014). Neurodegeneration with brain iron accumulation: An overview. Iranian Journal of Child Neurology, 8(4), 1–8.